Mather Group, LLC.

SEC CIK: 0001527641
Latest filing: Jul 27, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Mather Group, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2024

Holdings of RARE by Mather Group, LLC., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−110−100.0%	Sold out	Holders
Q3 2025	110	$3.31K	<0.1%	+110	New	Holders
Q3 2024	0	$0	0.0%	−2−100.0%	Sold out	Holders
Q2 2024	2	$93	<0.1%	+2	New	Holders